Synthesis of Nanohydroxyapatite via Euclea natalensis-Mediated Precipitation for Enhanced Artemisinin Loading and Release

05 March 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Developing drug delivery systems that mitigate difficulties and/or improve distribution and efficiency has been of great interest in recent years. In this work, a nanohydroxyapatite/Euclea natalensis system was designed via precipitation with three experimental parameters (reaction temperature, amount of template, and reaction drip-rate) for improved loading and release of the antimalarial drug artemisinin. Characterization confirmed synthesized nanomaterials with average particle sizes ranging from 17.09 to 27.67 nm. Calcination was found to reduce the surface area, pore size, and pore volume of the samples. The optimal spherical morphology was achieved using 1.20 g of material and a reaction drip rate of 1.5 mL/min at 50 °C, followed by calcination. However, greater adsorption efficiency was observed in the non-calcined samples due to higher values in surface area, pore size, and pore volume, with an increase in efficiency of up to 79.14% with the modification of the molar ratio of artemisinin/hydroxyapatite. There was up to 13.39% increase in drug loading efficiency in the sample with the template compared to the sample without the template, using a 1:2 molar ratio of artemisinin to nanohydroxyapatite. A controlled release between 20 min and 1560 min was satisfactorily obtained, following the Higuchi kinetic model.

Keywords

Nanohydroxyapatite
Drug delivery
Artemisinin
Euclea natalensis
Controlled release

Supplementary materials

Title
Description
Actions
Title
Supplementary Material
Description
Supplementary Material for the article "Synthesis of Nanohydroxyapatite via Euclea natalensis-Mediated Precipitation for Enhanced Artemisinin Loading and Release".
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.